Position in EXEL
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,941,841
+$537,148 QoQ
Shares Held
72,447
-8.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#197
of 754 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $65,105,395 across 33 Biotechnology names. EXEL ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,685 | $10,771,590 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,798 | $5,485,904 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
129,836 | $4,594,896 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
72,447 | $3,941,841 | |
| 5 | CYTK |
Cytokinetics Inc
|
38,651 | $3,292,678 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
40,203 | $3,276,946 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
55,287 | $3,163,522 | |
| 8 | MRNA |
Moderna, Inc.
|
40,868 | $2,861,986 |
All Filings in EXEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,941,841 | 72,447 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,404,693 | 79,382 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,766,925 | 85,944 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,618,210 | 87,608 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $4,198,884 | 95,256 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,689,231 | 99,925 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $3,476,187 | 104,390 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,824,372 | 108,839 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,816,524 | 125,346 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,354,567 | 141,364 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,594,253 | 149,823 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,337,871 | 152,763 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,149,480 | 164,808 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,286,404 | 169,315 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,705,867 | 168,695 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,587,686 | 165,031 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,749,827 | 180,107 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,774,486 | 166,497 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,008,266 | 164,566 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||